Comments

CASI Pharmaceuticals

CASINASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$5.90
0.376.69%
Last update: Oct 1, 4:55 PM
15 minutes delayed
CASI Pharmaceuticals (CASI) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

CASI Pharmaceuticals (NASDAQ:CASI) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for CASI Pharmaceuticals (CASI)?

A

There have been no specific sales or earnings guidance reported for CASI Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch